Similar articles

• Hypertrophic gastropathy resembling Ménétrier's disease in transgenic mice overexpressing transforming growth factor alpha in the stomach.

  Takagi H, Jhappan C, Sharp R, Merlino G. Takagi H, et al. J Clin Invest. 1992 Sep;90(3):1161-7. doi: 10.1172/JCI115936. J Clin Invest. 1992. PMID: 1522224 Free PMC article.
• Possible role of transforming growth factor alpha in the pathogenesis of Ménétrier's disease: supportive evidence form humans and transgenic mice.

  Dempsey PJ, Goldenring JR, Soroka CJ, Modlin IM, McClure RW, Lind CD, Ahlquist DA, Pittelkow MR, Lee DC, Sandgren EP, et al. Dempsey PJ, et al. Gastroenterology. 1992 Dec;103(6):1950-63. doi: 10.1016/0016-5085(92)91455-d. Gastroenterology. 1992. PMID: 1451986
• Role of vascular endothelial growth factor in protein loss of Ménétrier's disease.

  Takeda T, Mitsuyama K, Tsuruta O, Kuboyama S, Kitazaki S, Sata M. Takeda T, et al. Int J Mol Med. 2006 Oct;18(4):571-6. Int J Mol Med. 2006. PMID: 16964406
• Roles for transforming growth factor-alpha in the stomach.

  Coffey RJ, Romano M, Goldenring J. Coffey RJ, et al. J Clin Gastroenterol. 1995;21 Suppl 1:S36-9. J Clin Gastroenterol. 1995. PMID: 8774988 Review.
• Roles for transforming growth factor-alpha in gastric physiology and pathophysiology.

  Coffey RJ, Romano M, Polk WH, Dempsey PJ. Coffey RJ, et al. Yale J Biol Med. 1992 Nov-Dec;65(6):693-704; discussion 621-3. Yale J Biol Med. 1992. PMID: 1341072 Free PMC article. Review.